Chloe Orkin
- Virology top 0.1%
- HIV Research and Treatment 81
- Poxvirus research and outbreaks 12
- Infectious Diseases top 0.2%
- HIV/AIDS drug development and treatment 98
- HIV/AIDS Research and Interventions 75
- Emergency Medicine top 0.2%
- HIV-related health complications and treatments 28
- Hepatology top 1%
- Hepatitis C virus research 32
- Epidemiology top 1%
- HIV, Drug Use, Sexual Risk 15
- Hepatitis B Virus Studies 12
- Co-authors
- Hans‐Jürgen StellbrinkMartin FisherJürgen K. RockstrohPaul E. SaxMark NelsonDaniel PodzamczerAdriano LazzarinBrian Gazzard
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Chloe Orkin
157 papers receiving 5.8k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Virology 2.7k
- Infectious Diseases 3.8k
- Emergency Medicine 1.8k
- Hepatology 885
- Epidemiology 1.8k
Countries citing papers authored by Chloe Orkin
This map shows the geographic impact of Chloe Orkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Orkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Orkin more than expected).
Fields of papers citing papers by Chloe Orkin
This network shows the impact of papers produced by Chloe Orkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Orkin. The network helps show where Chloe Orkin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chloe Orkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 0 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 1 | |
| 12 | 2022 | 42 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 70 | |
| 16 | 2020 | 11 | |
| 17 | 2019 | 11 | |
| 18 | 2018 | 14 | |
| 19 | 2017 | 14 | |
| 20 | Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention? United Kingdom Collaborative HIV Cohort Study Group | 2009 | 7 |
About Chloe Orkin
Chloe Orkin is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 168 papers that have together received 6.0k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (98 papers), HIV Research and Treatment (81 papers), HIV/AIDS Research and Interventions (75 papers), Hepatitis C virus research (32 papers), HIV-related health complications and treatments (28 papers), HIV, Drug Use, Sexual Risk (15 papers), Hepatitis B Virus Studies (12 papers) and Poxvirus research and outbreaks (12 papers). The work is most often cited by research in Virology (2.7k citations), Infectious Diseases (3.8k citations) and Emergency Medicine (1.8k citations). Chloe Orkin has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Hans‐Jürgen Stellbrink, Martin Fisher, Jürgen K. Rockstroh, Paul E. Sax, Mark Nelson, Daniel Podzamczer, Adriano Lazzarin, Brian Gazzard, Xuelian Wei and David Dunn. Their work appears in journals such as The Lancet, JAMA and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.